BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $9,673,000 | -58.5% | 8,675,000 | -55.7% | 0.04% | -47.0% |
| Q4 2017 | $23,289,000 | +164.4% | 19,581,000 | +161.7% | 0.07% | +144.4% |
| Q4 2016 | $8,807,000 | -26.3% | 7,483,000 | -21.6% | 0.03% | -25.0% |
| Q3 2016 | $11,953,000 | +85.0% | 9,548,000 | +71.6% | 0.04% | +80.0% |
| Q2 2016 | $6,460,000 | -47.2% | 5,563,000 | -45.8% | 0.02% | -47.4% |
| Q1 2016 | $12,230,000 | -6.2% | 10,272,000 | +5.7% | 0.04% | -2.6% |
| Q4 2015 | $13,033,000 | -5.6% | 9,717,000 | -5.1% | 0.04% | -7.1% |
| Q3 2015 | $13,806,000 | -30.1% | 10,236,000 | -17.3% | 0.04% | -19.2% |
| Q2 2015 | $19,763,000 | +7.2% | 12,371,000 | +2.0% | 0.05% | +10.6% |
| Q1 2015 | $18,432,000 | +178.5% | 12,131,000 | +101.6% | 0.05% | +176.5% |
| Q3 2014 | $6,619,000 | -49.4% | 6,017,000 | -51.3% | 0.02% | +13.3% |
| Q2 2014 | $13,070,000 | +95.3% | 12,352,000 | +105.8% | 0.02% | 0.0% |
| Q1 2014 | $6,692,000 | +1.9% | 6,002,000 | -1.8% | 0.02% | 0.0% |
| Q4 2013 | $6,569,000 | – | 6,114,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 12,400,000 | $1,326,025,000,000 | 1.66% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $8,643,000 | 0.79% |
| OAKTREE CAPITAL MANAGEMENT LP | 37,500,000 | $40,523,000 | 0.74% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 46,800,000 | $50,350,000 | 0.63% |
| Jabre Capital Partners S.A. | 6,500,000 | $7,035,000 | 0.54% |
| Nicholas Investment Partners, LP | 6,470,000 | $6,919,000 | 0.53% |
| Polar Asset Management Partners Inc. | 10,000,000 | $10,788,000 | 0.46% |
| AVIVA PLC | 50,700,000 | $54,594,000 | 0.46% |
| Man Investments (CH) AG | 1,000,000 | $1,082,000 | 0.44% |
| RWC Asset Management LLP | 3,500,000 | $3,769,000 | 0.40% |